Literature DB >> 19266258

Comparative diagnostic evaluation with MR cholangiopancreatography, ultrasonography and CT in patients with pancreatobiliary disease.

S Maurea1, O Caleo, C Mollica, M Imbriaco, P P Mainenti, C Palumbo, M Mancini, L Camera, M Salvatore.   

Abstract

PURPOSE: The aim of this study was to directly compare the results of magnetic resonance cholangiopancreatography (MRCP) with those of ultrasonography (US) and multislice computed tomography (MSCT) in the diagnosis of pancreaticobiliary diseases.
MATERIALS AND METHODS: A total of 70 patients (41 men, 29 women) aged 22-89 years were studied either before (n=59) or after cholecystectomy (n=11) for biliary lithiasis. Clinical signs and symptoms were jaundice (n=15), abdominal pain (n=37) and proven biliary lithiasis (n=18). MRCP was performed in all patients, whereas abdominal US was performed in 55 (group 1) and MSCT in 37 (group 2) patients. A regional evaluation of the main structures of the pancreaticobiliary system was performed: gallbladder and cystic duct, intra- and extrahepatic bile ducts and main pancreatic duct. Histology (n=27), biopsy (n=5), endoscopic retrograde cholangiopancreatography (ERCP) (n=28) and/or clinical-imaging follow-up (n=10) were considered standards of reference. In particular, patients were classified as showing benign (n=47) or malignant (n=12) lesions or normal biliary anatomy (n=11).
RESULTS: In group 1, the results of MRCP and US were concordant in the majority (92%) of cases; however, statistically significant discordance (p<0.01) was found in the evaluation of the extrahepatic ducts, with nine cases (16%) of middle-distal common bile duct stones being detected on MRCP only. In group 2, the results of MRCP and MSCT were also concordant in most cases (87%). However, findings were significantly discordant when the intra- and extrahepatic ducts were analysed, with seven (19%) and six (16%) cases, respectively, of lithiasis being detected on MRCP only (p<0.01 for both).
CONCLUSIONS: The results of our study confirm the diagnostic potential of MRCP in the study of the pancreaticobiliary duct system. In particular, the comparison between MRCP and US and MSCT indicates the superiority of MRCP in evaluating bile ducts and detecting stones in the common bile duct.

Entities:  

Mesh:

Year:  2009        PMID: 19266258     DOI: 10.1007/s11547-009-0374-x

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  27 in total

1.  Three-dimensional ultrasound cholangiography: a new noninvasive technique for evaluation of biliary obstruction.

Authors:  M Hünerbein; C Stroszczynski; R Felix; P M Schlag
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

Review 2.  ERCP and MRCP--when and why.

Authors:  J G Albert; J F Riemann
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-06       Impact factor: 3.043

Review 3.  Imaging of intrahepatic and hilar cholangiocarcinoma.

Authors:  B I Choi; J M Lee; J K Han
Journal:  Abdom Imaging       Date:  2004-06-08

4.  Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up.

Authors:  G Carbognin; G Zamboni; L Pinali; E Dalla Chiara; V Girardi; R Salvia; R Pozzi Mucelli
Journal:  Abdom Imaging       Date:  2005-12-05

5.  MR versus multislice CT cholangiography in evaluating patients with obstruction of the biliary tract.

Authors:  F Zandrino; P Curone; L Benzi; M L Ferretti; F Musante
Journal:  Abdom Imaging       Date:  2004-11-17

6.  Malignant obstructive jaundice: comparison of MRCP and ERCP in the evaluation of distal lesions.

Authors:  Ernesto Di Cesare; Edoardo Puglielli; Osvaldo Michelini; Maria Antonietta Pistoi; Loreto Lombardi; Mauro Rossi; Antonio Barile; Carlo Masciocchi
Journal:  Radiol Med       Date:  2003 May-Jun       Impact factor: 3.469

7.  Detection of common bile duct stones: comparison between endoscopic ultrasonography, magnetic resonance cholangiography, and helical-computed-tomographic cholangiography.

Authors:  Shintaro Kondo; Hiroyuki Isayama; Masaaki Akahane; Nobuo Toda; Naoki Sasahira; Yosuke Nakai; Natsuyo Yamamoto; Kenji Hirano; Yutaka Komatsu; Minoru Tada; Haruhiko Yoshida; Takao Kawabe; Kuni Ohtomo; Masao Omata
Journal:  Eur J Radiol       Date:  2005-05       Impact factor: 3.528

8.  US, MRCP, CCT and ERCP: a comparative study in 131 patients with suspected biliary obstruction.

Authors:  Francesco Saverio Ferrari; Federica Fantozzi; Laura Tasciotti; Francesco Vigni; Francesca Scotto; Paolo Frasci
Journal:  Med Sci Monit       Date:  2005-03

9.  Magnetic resonance-cholangiopancreatography in the diagnosis of biliopancreatic diseases.

Authors:  D Lomanto; P Pavone; A Laghi; V Panebianco; P Mazzocchi; F Fiocca; E Lezoche; R Passariello; V Speranza
Journal:  Am J Surg       Date:  1997-07       Impact factor: 2.565

10.  A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures.

Authors:  Thomas Rösch; Alexander Meining; Silke Frühmorgen; Christian Zillinger; Volker Schusdziarra; Karin Hellerhoff; Meinhard Classen; Hermann Helmberger
Journal:  Gastrointest Endosc       Date:  2002-06       Impact factor: 9.427

View more
  10 in total

Review 1.  Magnetic resonance imaging of pancreatitis: an update.

Authors:  Sriluxayini Manikkavasakar; Mamdoh AlObaidy; Kiran K Busireddy; Miguel Ramalho; Viragi Nilmini; Madhavi Alagiyawanna; Richard C Semelka
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

2.  Magnetic resonance cholangiopancreatography and contrast-enhanced magnetic resonance cholangiopancreatography versus endoscopic ultrasonography in the diagnosis of extrahepatic biliary pathology.

Authors:  S Palmucci; L A Mauro; S La Scola; S Incarbone; G Bonanno; P Milone; A Russo; G C Ettorre
Journal:  Radiol Med       Date:  2010-02-22       Impact factor: 3.469

3.  Quantitative MRCP assessment of pancreatic exocrine reserve and its correlation with faecal elastase-1 in patients with chronic pancreatitis.

Authors:  R Manfredi; S Perandini; W Mantovani; L Frulloni; N Faccioli; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2012-01-07       Impact factor: 3.469

Review 4.  Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones.

Authors:  Vanja Giljaca; Kurinchi Selvan Gurusamy; Yemisi Takwoingi; David Higgie; Goran Poropat; Davor Štimac; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26

Review 5.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

Review 6.  Ultrasound versus liver function tests for diagnosis of common bile duct stones.

Authors:  Kurinchi Selvan Gurusamy; Vanja Giljaca; Yemisi Takwoingi; David Higgie; Goran Poropat; Davor Štimac; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26

7.  The correlation between ultrasonography and histology in the search for gallstones.

Authors:  M Ahmed; R Diggory
Journal:  Ann R Coll Surg Engl       Date:  2010-10-15       Impact factor: 1.891

8.  Lymphoepithelioma‑Like Cholangiocarcinoma with Hepatitis C Virus Infection Treated by Microwave Ablation: A Literature Review and Case Report.

Authors:  Xiaolin Guo; Pujun Gao; Xu Li; Huifan Ji; Dezhi Zhang; Meishan Jin
Journal:  Cancer Manag Res       Date:  2022-07-04       Impact factor: 3.602

9.  CT vs. MRCP in choledocholithiasis jaundice.

Authors:  I Petrescu; A M Bratu; S Petrescu; B V Popa; D Cristian; T Burcos
Journal:  J Med Life       Date:  2015 Apr-Jun

10.  Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy.

Authors:  Francesco Izzo; Vincenza Granata; Roberta Fusco; Valeria D'Alessio; Antonella Petrillo; Secondo Lastoria; Mauro Piccirillo; Vittorio Albino; Andrea Belli; Salvatore Tafuto; Antonio Avallone; Renato Patrone; Raffaele Palaia
Journal:  J Clin Med       Date:  2021-03-22       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.